Irish medical technology firm Medtronic has agreed to distribute artificial intelligence (AI)-based stroke...
Genetic test could enable new targeted prostate cancer therapy
A new study by The Institute of Cancer Research, London (ICR) has shown that a genetic test for faults in DNA repair could enable targeted nuclear treatments for patients with prostate cancer.
Medtronic to offer Viz.ai’s AI stroke detection software in US
Irish medical technology firm Medtronic has agreed to distribute artificial intelligence (AI)-based stroke care solutions provider Viz.ai’s new technology across US centres.
Study finds common blood tests could predict diabetes
A new study of treatment data from the US Department of Veterans Affairs (VA) has revealed that routine blood tests for plasma glucose may identify patients who will develop diabetes in the future.
Elekta gets Canadian clearance for Unity MR/RT system
Sweden-based Elekta, a precision radiation medicine solutions provider, has received regulatory clearance from the Canadian Nuclear Safety Commission for clinical use of its Unity magnetic resonance radiation therapy (MR/RT) system.
Pear Therapeutics seeks approval for new digital therapeutic Somryst
Pear Therapeutics has submitted an application to the US Food and Drug Administration (FDA) for marketing approval of its new product, Somryst.
NUS develops electronic skin with enhanced sense of touch
Researchers at the National University of Singapore (NUS) have developed an artificial nervous system that could offer an enhanced sense of touch for prosthetic devices and robots.
Meet Pexxi, the AI-powered genetic test clarifying contraception
Hailed as the saviour of the modern woman during the sexual revolution of the 1960s, oral contraceptive pills have begun to fall out of favour due to the unpleasant side effects they often induce. With so many different options now available, patients often end up in a game of contraception roulette as they try and find a pill that’s right for them – but a boundary-pushing AI start-up wants to see that all change.
CVS Health trials at-home haemodialysis device HemoCare
Drugstores chain CVS Health has launched a clinical trial to assess at-home haemodialysis device HemoCare, which has been designed by DEKA Research & Development.
Novian gets European approval for Novilase Breast Therapy
US-based medical device maker Novian Health has secured CE-Mark approval to market its Novilase Breast Therapy in the European Union (EU) and Switzerland.
Read our magazine
Medical Technology is the essential reading material for decision-makers in the medical device industry, bringing you the latest news and analysis in an exciting, interactive format.